Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
NARS PURE RADIANT TINTED MOISTURIZER
- Manufacturer
- NARS Cosmetics
- Effective date
- 2018-11-27
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 00:44:47
Label at a glance#
ProductNARS PURE RADIANT TINTED MOISTURIZER Finland
Active ingredientOCTINOXATE, TITANIUM DIOXIDE
Label structure21 sections
Dosage and administration
For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: limit time in the su...
Storage and handling
protect this product in this container from excessive heat and direct sun.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active ingredients | Purpose |
|---|---|
| OCTINOXATE 7.4% | Sunscreen |
| TITANIUM DIOXIDE 6.1% | Sunscreen |
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
OTC - DO NOT USE SECTION
For external use only
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least every 2 hours
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
- children under 6 months: Ask a doctor
Inactive Ingredients
Water • Dimethicone • Butylene Glycol • Propanediol • Diethylhexyl Succinate • Glycerin • Nylon-12 • Cyclomethicone • PEG-9 Polydimethylsiloxyethyl Dimethicone • PEG-10 Dimethicone • Aluminum Hydroxide • Diphenylsiloxy Phenyl Trimethicone • Disteardimonium Hectorite • Sorbitan Sesquiisostearate • Stearic Acid • Phenoxyethanol • Polymethylsilsesquioxane • Fragrance • Dimethicone/Vinyl Dimethicone Crosspolymer • Trisodium EDTA • Aluminum Distearate • Talc • Ascorbyl Glucoside • Polysilicone-2 • Vibrio Alginolyticus Ferment Filtrate • Tocopherol • Alteromonas Ferment Filtrate • Sea Salt • Hydrogen Dimethicone • BHT • Algae Extract • Sodium Metabisulfite • Curcuma Longa (Turmeric) Root Extract • Potassium Sorbate • [(May Contain): Titanium Dioxide • Iron Oxides] •
Other information
- protect this product in this container from excessive heat and direct sun.
Questions or comments?
Call toll free 1-888-788-NARS
SPL UNCLASSIFIED SECTION
NARS COSMETICS
NEW YORK, NY 10022 DIST.
NEW YORK - SE PARIS - LONDON (UK) W3 5RH
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - FINLAND
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - ALASKA
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - ANNAPURNA
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - ST. MORITZ
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - CUBA
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - MALAGA
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - SEYCHELLES
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - MARTINIQUE
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - POLYNESIA
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - TERRE-NEUVE
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - GROENLAND
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
PRINCIPAL DISPLAY PANEL - 50 mL Tube Carton - CUZCO
NARS
PURE RADIANT
TINTED MOISTURIZER
BROAD SPECTRUM
SPF 30 SUNSCREEN
NET WT.
1.9 Oz. 50 mL
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 2 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 2 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 2 | |
| .ALPHA.-TOCOPHEROL | INACTIVE INGREDIENT | H4N855PNZ1 | 2 | |
| ALUMINUM DISTEARATE | INACTIVE INGREDIENT | 7P1HP1B9UI | 2 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 2 | |
| ASCORBYL GLUCOSIDE | INACTIVE INGREDIENT | 2V52R0NHXW | 2 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 2 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 2 | |
| CYCLOMETHICONE | INACTIVE INGREDIENT | NMQ347994Z | 2 | |
| DIETHYLHEXYL SUCCINATE | INACTIVE INGREDIENT | 69W9UMG3P8 | 2 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 2 | |
| DIPHENYLSILOXY PHENYL TRIMETHICONE | INACTIVE INGREDIENT | I445L28B12 | 2 | |
| EDETATE TRISODIUM | INACTIVE INGREDIENT | 420IP921MB | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | 2 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | 2 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | 2 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 2 | |
| NYLON-12 | INACTIVE INGREDIENT | 446U8J075B | 2 | |
| PEG-10 DIMETHICONE (600 CST) | INACTIVE INGREDIENT | 8PR7V1SVM0 | 2 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| POLYMETHYLSILSESQUIOXANE (4.5 MICRONS) | INACTIVE INGREDIENT | 59Z907ZB69 | 2 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 2 | |
| PROPANEDIOL | INACTIVE INGREDIENT | 5965N8W85T | 2 | |
| SEA SALT | INACTIVE INGREDIENT | 87GE52P74G | 2 | |
| SODIUM METABISULFITE | INACTIVE INGREDIENT | 4VON5FNS3C | 2 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 2 | |
| TURMERIC | INACTIVE INGREDIENT | 856YO1Z64F | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- NARS PURE RADIANT TINTED MOISTURIZER Finland
- OCTINOXATE and TITANIUM DIOXIDE
- OCTINOXATE
- TITANIUM DIOXIDE
- WATER
- DIMETHICONE
- BUTYLENE GLYCOL
- PROPANEDIOL
- DIETHYLHEXYL SUCCINATE
- GLYCERIN
- NYLON-12
- CYCLOMETHICONE
- PEG-10 DIMETHICONE (600 CST)
- ALUMINUM HYDROXIDE
- DIPHENYLSILOXY PHENYL TRIMETHICONE
- STEARIC ACID
- PHENOXYETHANOL
- POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
- EDETATE TRISODIUM
- ALUMINUM DISTEARATE
- ASCORBYL GLUCOSIDE
- TALC
- .ALPHA.-TOCOPHEROL
- SEA SALT
- BUTYLATED HYDROXYTOLUENE
- SODIUM METABISULFITE
- TURMERIC
- POTASSIUM SORBATE
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- FERROSOFERRIC OXIDE
- PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE
- SORBITAN SESQUIISOSTEARATE
- DISTEARDIMONIUM HECTORITE
- NARS PURE RADIANT TINTED MOISTURIZER Alaska
- NARS PURE RADIANT TINTED MOISTURIZER Annapurna
- NARS PURE RADIANT TINTED MOISTURIZER St. Moritz
- NARS PURE RADIANT TINTED MOISTURIZER Cuba
- NARS PURE RADIANT TINTED MOISTURIZER Malaga
- NARS PURE RADIANT TINTED MOISTURIZER Seychelles
NDC Codes#
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | TABLET / RECTAL | 2 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | IMPLANT / SUBCUTANEOUS | 1.04 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | TABLET, FILM COATED / ORAL | 0.2 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION / INTRAVENOUS | NA | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION / SUBCUTANEOUS | 43 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | SOLUTION / IONTOPHORESIS | 0.05 %w/v | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR | 0.15 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 0.15 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | DROPS / ORAL | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, EXTENDED RELEASE / ORAL | 5 mg | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION / INFILTRATION | 0.5 %w/v | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / BUCCAL | 1 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION / INTRAMUSCULAR | 27.5 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / VAGINAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | TABLET / SUBLINGUAL | 1 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION / ORAL | 14 mg | ||
| FERROSOFERRIC OXIDE | FERROSOFERRIC OXIDE | XM0M87F357 | CAPSULE, COATED / ORAL | 0.11 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| TALC | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| FERRIC OXIDE YELLOW | FERRIC OXIDE YELLOW | EX438O2MRT | GRANULE, FOR SUSPENSION / ORAL | 11 mg | ||
| .ALPHA.-TOCOPHEROL | .ALPHA.-TOCOPHEROL | H4N855PNZ1 | TABLET, FILM COATED / ORAL | 246 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / SUBLINGUAL | 1 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM / BUCCAL | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION / EPIDURAL | 0.05 %w/v | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | DROPS / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / VAGINAL | 0.05 %w/w | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION / INTRAPERITONEAL | 0.33 %w/v | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | SUSPENSION / ORAL | 40 mg | ||
| TALC | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | POWDER, FOR SUSPENSION / ORAL | 1 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | TABLET / BUCCAL | 0.4 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION, EMULSION / INTRAVENOUS | 0.03 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| FERRIC OXIDE RED | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE / ORAL | 5 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | OINTMENT / TOPICAL | 57 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SHAMPOO, SUSPENSION / TOPICAL | 3 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | PELLET / SUBCUTANEOUS | 0.97 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e2f2bcf5-9a55-4d10-b921-4f5297a3c2ab | 99ae528d-88b5-43a3-8e5e-d9e88e0ca9b4 | 2023-09-07 | Warnings | 99ae528d-88b5-43a3-8e5e-d9e88e0ca9b4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.